Andrew D. White

2.7k total citations · 2 hit papers
37 papers, 2.0k citations indexed

About

Andrew D. White is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Andrew D. White has authored 37 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Organic Chemistry. Recurrent topics in Andrew D. White's work include Receptor Mechanisms and Signaling (10 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Neuropeptides and Animal Physiology (5 papers). Andrew D. White is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Neuropeptides and Animal Physiology (5 papers). Andrew D. White collaborates with scholars based in United States, France and Poland. Andrew D. White's co-authors include Steven V. Ley, William P. Griffith, Guy Perkins, Akos A. Gerencser, Ella Bossy‐Wetzel, Blaise Bossy, Mark H. Ellisman, Jean‐Claude Martinou, Jiankun Cui and Hua Yuan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Andrew D. White

37 papers receiving 2.0k citations

Hit Papers

Preparation and use of tetra-n-butylammonium per-ruthenat... 1987 2026 2000 2013 1987 2006 200 400 600

Peers

Andrew D. White
Comparison fields: 5 of 110
  • Molecular Biology 1.1k
  • Organic Chemistry 666
  • Cellular and Molecular Neuroscience 260
  • Physiology 224
  • Cancer Research 222
Alex M. Nadzan United States
Donald S. Karanewsky United States
Alan L. Maycock United States
Hiroyuki Miyachi Japan
David A. Griffith United States
Heather Hoover United States
Michael J. Coghlan United States
Andrew J. Souers United States
Hongyu Zhao United States
Philip V. LoGrasso United States
Alex M. Nadzan United States View profile →
Citations per field, relative to Andrew D. White
Andrew D. White · 1×
Citations per year, relative to Andrew D. White
Andrew D. White · 1×

Countries citing papers authored by Andrew D. White

Since Specialization
Citations

This map shows the geographic impact of Andrew D. White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. White more than expected).

Fields of papers citing papers by Andrew D. White

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. White. The network helps show where Andrew D. White may publish in the future.

Co-authorship network of co-authors of Andrew D. White

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. White. A scholar is included among the top collaborators of Andrew D. White based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. White. Andrew D. White is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 The oxylipin analog CS585 prevents platelet activation and thrombosis through activation of the prostacyclin receptor Blood Adriana Yamaguchi, Sylviane Lambert et al. 9
2 Histone deacetylase 6 inhibition restores leptin sensitivity and reduces obesity Nature Metabolism Işın Çakır, Rushita A. Bagchi et al. 46
3 An erythroid-to-myeloid cell fate conversion is elicited by LSD1 inactivation Blood Lei Yu, Yu Wang et al. 15
4 Synthesis and structure-activity relationships of thieno[2,3-d]pyrimidines as atypical protein kinase C inhibitors to control retinal vascular permeability and cytokine-induced edema Bioorganic & Medicinal Chemistry Xuwen Liu, Michael W. Wilson et al. 1
5 S-3-Carboxypropyl-l-cysteine specifically inhibits cystathionine γ-lyase–dependent hydrogen sulfide synthesis Journal of Biological Chemistry Pramod Kumar Yadav, Victor Vitvitsky et al. 15
6 cis-1-Oxo-heterocyclyl-4-amido cyclohexane derivatives as NPY5 receptor antagonists Bioorganic & Medicinal Chemistry Letters Bin Chen, Chien‐An Chen et al. 3
7 Fused thiazolyl alkynes as potent mGlu5 receptor positive allosteric modulators Bioorganic & Medicinal Chemistry Letters Mathivanan Packiarajan, Allen T. Hopper et al. 6
8 Azetidinyl oxadiazoles as potent mGluR5 positive allosteric modulators Bioorganic & Medicinal Chemistry Letters Mathivanan Packiarajan, Andrew D. White et al. 12
9 N-Aryl pyrrolidinonyl oxadiazoles as potent mGluR5 positive allosteric modulators Bioorganic & Medicinal Chemistry Letters Mathivanan Packiarajan, Andrew D. White et al. 17
10 Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity Cell Death and Differentiation Yulia E. Kushnareva, Akos A. Gerencser et al. 92
11 Hydration of Zwitterionic Glycine Betaine and Analogues Through Molecular Simulation Biophysical Journal Andrew D. White, Shaoyi Jiang 1
12 Strategies to lower the Pgp efflux liability in a series of potent indole azetidine MCHR1 antagonists Bioorganic & Medicinal Chemistry Letters Kai Lǚ, Yu Jiang et al. 11
13 Discovery of PF-00217830: Aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder Bioorganic & Medicinal Chemistry Letters Douglas S. Johnson, Chung Sik Choi et al. 19
14 6-Alkoxyisoindolin-1-one based dopamine D2 partial agonists as potential antipsychotics Bioorganic & Medicinal Chemistry Letters David A. Favor, Andrew D. White et al. 8
15 Synthesis of monofluorinated 1-(naphthalen-1-yl)piperazines Tetrahedron Letters Joseph T. Repine, Douglas S. Johnson et al. 11
16 Nitric oxide‐induced mitochondrial fission is regulated by dynamin‐related GTPases in neurons breakdown → The EMBO Journal Hua Yuan, Akos A. Gerencser et al. 561
17 A Rationalization of the Acidic pH Dependence for Stromelysin-1 (Matrix Metalloproteinase-3) Catalysis and Inhibition Journal of Biological Chemistry Linda L. Johnson, A.G. Pavlovsky et al. 64
18 X‐ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: Implications for inhibitor selectivity Protein Science A.G. Pavlovsky, Mark Williams et al. 65
19 Emerging Therapeutic Advances for the Development of Second Generation Matrix Metalloproteinase Inhibitors Current Pharmaceutical Design Andrew D. White, Thomas Bocan et al. 37
20 A method utilizing human lymphocytes with in vitro metabolic activation for assessing chemical mutagenicity by sister-chromatid exchange analysis Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis Andrew D. White et al. 30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026